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1. Introduction 
Macrophages are known to take up “invaders” such as pathogens and viruses mainly by 
phagocytosis to protect the host from infections by them. This process of phagocytosis is 
disadvantageous in general for exhibition of an efficient pharmacological effect of particle 
formulations containing drugs, because the uptake of particles by macrophages reduces the 
extracellular drug concentration. Hence, it is important to understand what properties of 
particles are advantageous or disadvantageous for phagocytic uptake by macrophages. 
Modification of particles by polyethylene glycol (PEG), which forms a hydrated phase on 
the surface of particles, enables long-lasting circulation of such particles in the bloodstream 
by circumventing their uptake by macrophage cells [1].  
In contrast, particle formulations that are easily taken up by macrophages would be highly 
advantageous for macrophage-targeting drug delivery [2]. In this case, a typical example is 
the treatment of tuberculosis (TB). Namely, Mycobacterium tuberculosis (MTB) cells are easily 
trapped in the phagosomes of alveolar macrophages. However, these cells are not digested 
by macrophages, because the fusion of the MTB-containing phagosomes with lysosomes, 
which are indispensable for the digestion of bacteria inside phagosomes, is inhibited. As a 
result, MTB cells proliferate and accumulate inside macrophages [3]. Hence, the delivery of 
particles containing antituberculosis agents to alveolar macrophages would be expected to 
be effective for TB therapy.  
As summarized in Figure 1, endocytic uptake including phagocytosis is classified according 
to the mechanism of vesicle formation as well as the size of particles ingested [4-7]. 
Phagocytosis is performed by specialized cells such as macrophages, and it plays a role in 
the clearance of particles having a diameter greater than 0.5 m. On the other hand, 
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pinocytosis occurs in all cells, including macrophages and cancer cells, for obtaining 
nutrients and biological mediators. It is noteworthy that macropinocytosis covers a broad 
range of particle sizes from 100 nm to 5 m [8-10].  
 
Figure 1. Classification of endocytosis in relation to particle sizes favorable for ingestion.  
In this chapter, features of phagocytosis of particles in terms of particle properties, as well as 
phagocytosis-induced physiological events of macrophages, are described. In addition, the 
promising aspect of clinical treatment by the utilization of endocytosis-mediated drug action 
is reviewed.  
2. Effect of particle properties on endocytosis 
Drug-containing particle formulations are commonly used for delivery of drugs. The 
particle base is the most important part of a formulation. Poly (lactic-glycolic) acid (PLGA) 
is one of the candidates for drug-containing particle formulations, because PLGA is 
biodegradable and biocompatible [11]. Drug release from the particles and its sustainability 
can be regulated by changing the molecular weight and composition of the lactate and 
glycolate moieties of PLGA [12].  
Phagocytic uptake of particles by macrophage cells proceeds as follows: 1) access of particles 
to the surface of the macrophage membrane, 2) particle recognition by phagocytic receptors 
on the macrophage membrane, and 3) dynamic changes in membrane structure (protrusion 
or invagination). Particle size, shape, and surface properties affect efficient entrapment and 
subsequent uptake by macrophages.  
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2.1. Particle size 
Particle size is likely the primary factor that governs endocytic uptake of particles. The 
optimum size of particles for efficient endocytic uptake varies according to the cell type. 
Macrophage cells are able to ingest large particles having a diameter between 1 m and 10 
m to eliminate invaders from outside the body [13,14]. The optimal sizes of the particles for 
the uptake by alveolar macrophages range between 3 m and 6 m [15], but those by 
peritoneal macrophages and peripheral blood mononuclear cells are reportedly from 0.3 m 
to 1.1 m [16-18]. The uptake mechanism of the particles, such as 3-m particles, was 
interpreted by the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory [19]. 
Nanoparticles are advantageous for attacking carcinoma cells, which mainly originate from 
epithelial cells. The optimal size of the particles for the uptake by carcinoma cells was reported 
to be around 50 nm, as determined by the use of gold nanoparticles [20]. Besides micrometer-
size particles, macrophages also take up nano-size particles [21]. The uptake of nano-size 
particles mainly proceeds via pinocytosis in such a way that the rate of pinocytosis is 
dependent on the extracellular particle concentration and time of exposure. For ingestion of 
liquid phase, this rate for mouse fibroblast L cells is 18.7 m3/hr/cell, which value is less than 
that for mouse resident peritoneal macrophages, 46.5 m3/hr/cell [22,23]. Hence, 
understanding of particle properties other than size is also important for particle delivery.  
2.2. Shape 
Particle shape is another major factor affecting endocytic uptake by macrophages. The 
macrophage membrane undergoes structural changes in such a way that the membrane 
spreads around the particle, starting from the initial contact site between particle and 
membrane; and the progression of endocytic uptake of particles is dependent on the contact 
angle between particle and macrophage membrane. For example, an elliptical disk-shaped 
particle is internalized along its long axis when the particle has attached perpendicularly to 
the cell membrane, in which case the contact angle is small [24]. In this case, the membrane 
spreads symmetrically around the particle, engulfing it. In contrast, attachment when the 
short axis is perpendicular to the membrane increases the angle of contact and the number 
of contact points with the membrane, which then starts to spread asymmetrically. As a 
result, the particle is not engulfed. However, when the long axis of particles ranges from 2-3 
m, which corresponds to that of most bacteria, maximum attachment to macrophage cells 
occurs; and engulfment is successful even though the angle of contact is large [25].  
2.3. Surface properties 
Most mammalian cells including macrophage cells have negative charges on their surface 
[26,27]. As the loss of the negative surface charge of the membrane is thought to influence 
protein localization during endocytosis [28], the surface charge of particles is thought to be 
also critical for endocytic uptake. In fact, it is reported that changes in cellulose particles by the 
introduction of extremely negatively charged sulphoethyl residues or of positively charged 
diethylaminoethyl groups affect the endocytic uptake by mouse peritoneal macrophage cells 
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and that the endocytic uptake is the lowest for particles without having surface charge, as 
determined in terms of zeta potential [29].  
Charge density is also important. The Ohshima theory, based on the analysis of the membrane 
surface in terms of electrophoretic “softness” and the density of the fixed charge [30], will be 
effective for understanding of the interaction of particles with cell membranes [31]. 
Polystyrene particles having electrophoretic softness and a low negative electrical charge 
density by the introduction of primary amine and carboxyl groups on their surface were 
reported to be more susceptible to endocytic uptake by rat alveolar macrophage cells than 
those having more rigid and higher electrical charge density by the introduction of hydroxyl 
and sulfate groups [13].  
2.4. Particle formulations 
Particle formulations affect directly the interaction of particles with the endocytic receptors 
of macrophage cells. The exposure of the phosphatidylserine moiety on the membrane of 
apoptotic lymphocytes is important for their removal by endocytosis by macrophage cells 
through recognition via scavenger receptors on the macrophages [32]. Based on this 
mechanism, liposomes containing phosphatidylserine are more susceptible to uptake by 
macrophage-like HL-60RG cells than those containing phosphatidylethanolamine or 
phosphatidic acid [33].  
PLGA has been commonly used as a base of particle formulations. Macrophage cells eat PLGA 
particles more efficiently than polystyrene latex ones. It is noteworthy that phagocytosis of 
PLGA particles by alveolar macrophage cells stimulates their phagocytic activity in such a way 
that their uptake increases both the population of phagocytic macrophage cells and the 
number of particles that have been taken up by individual macrophage [34]. However, the 
mechanism of interaction of PLGA with macrophage cells is still unknown. 
3. Induction of inflammatory responses by endocytosis 
Macrophage cells patrol around the tissue where they reside and play a central role in the 
clearance of invaders. The total surface area of human alveoli is approx. 70 m2, where 23 billion 
alveolar macrophage cells reside [35,36]. Namely, a single macrophage cell should monitor 
invaders in an area of a square with a side length of 55 m. When macrophage cells encounter 
invaders, the cells eliminate them by phagocytosis and subsequent digestion with lysosomal 
enzymes. Simultaneously, macrophage cells generate inflammatory mediators, working as 
signals to inform the surrounding cells that invaders are coming. Macrophage cells also 
recognize drug carrier particles as invaders, and then, “undesirable” immune responses such 
as the production of antibody and inflammatory mediators take place. Hence, silent nature 
toward macrophage cell functions is required for efficient drug carrier particles.  
In the case of endocytosis-mediated drug action (see section 5), high particle uptake by 
macrophages is favorable. Such efficient uptake will be achieved by up-regulation of endocytic 
activity, but this action may trigger undesirable immune responses from macrophages. If 
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efficient particle uptake is not associated with the induction of the undesirable responses, the 
particles could be very useful as drug carriers. As summarized in Table 1, PLGA particles are 
those having such a desirable silent nature regarding inflammatory responses, although they 
are yet well phagocytosed by macrophages compared with polystyrene latex (PSL) particles 
[34,37]. Namely, the PLGA particle behaves like a “Ninja,” having stealth and concealment 
activities. However, it is still unknown how particle formulation and modification are relevant 
to this silent nature. In this section, we review two distinct pathways involved in signal 
transduction to generate inflammatory mediators, one using phagocytic receptors and the 
other, pattern recognition receptors (PRRs).  
 
Responses 
Particles
PLGA PSL LPS 
Cell death - + ++ 
TNF- - + ++ 
NO - + ++ 
IL-10 - - + 
TGF- - + - 
Phagostimulation + -  
These data are summarized from reports [34,37]. Rat alveolar macrophage cells (NR8383)  
were exposed to PLGA and PSL particles at a number 10 times greater than the cell number. LPS existing in micellar 
form in the incubation medium was used at the concentration of 1 g/mL as a reference. (-), no responses; (+), mild 
responses; (++), significantly high response than (+). 
Table 1. Alveolar macrophage cellular responses induced by particle uptake. 
3.1. Phagocytosis-mediated inflammatory response 
Phagocytic cells, such as macrophages, monocytes, and polymorphonuclear cells, take up 
particles and pathogens typically with sizes of more than 0.5 m to clear them from the 
body mainly by phagocytosis [4,38]. In the case of macrophages, the ingestion of particles 
proceeds in such a way that the interaction of the particles with phagocytic receptors causes 
extension of pseudopods from the plasma membrane to capture the particles, which action 
is followed by engulfment by these phagocytes [5]. This phagocytic mechanism, called the 
“zipper” model, requires a reorganization of the actin-based cytoskeleton underlying the 
region of plasma membrane in contact with the particles and induces signal transduction 
through the Fc receptor (FcR) and complement-receptor 3 (CR3) [39].  
The cross-linking of the FcR by particles simultaneously initiates a series of signal 
transduction events mediated by multiple protein tyrosine kinases, phosphoinositide, and 
free arachidonic acid [40-42]. In the case of monocytes, the cross-linking of FcR by IgG 
initiates the release of TNF-, IL-1, IL-6, IL-8, and monocyte chemoattractant protein-1 
(MCP-1), which molecules are classified as T helper 1 (TH1) cytokines [43-47]. Macrophage 
cells are also stimulated by the cross-linking of FcR by IgG; and these cells generate TNF- 
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through MAPK signal transduction, leading to NF-B activation [48,49]. In the presence of 
IL-3 and a high density of IgG, IL-4 and IL-10 of the TH2 inflammatory cytokine family are 
synthesized in macrophage cells by the cross-linking via IgG [50,51]. Signal transduction 
initiated from FcRs is involved in inflammatory immune responses.  
In contrast, CR3-mediated phagocytosis by macrophages, which is cooperative with FcR-
mediated phagocytosis [52], seems to be involved in anti-inflammatory responses rather 
than in inflammatory responses, though various signal transductions mediated by tyrosine 
kinase are initiated from CR3 [53]. Generation of IL-12 in human monocytes is known to be 
stimulated by phagocytosis of Staphylococcus aureus. However, treatment of the phagocytic 
monocytes with iC3b, the natural CR3 ligand, down-regulates the generation of IL-12, 
suggesting that CR3 suppresses the inflammatory response [54]. In addition, ligation of CR3 
suppresses the release of TH1 cytokines, such as TNF-, IL-6 and IL-12, and the TH2 cytokine 
IL-10 from LPS-stimulated bone marrow-derived mouse dendritic cells [55]. Hence, it is 
possible that CR3 is associated with the silent nature of the entry of particles, such as PLGA 
particles, into phagocytic cells. 
3.2. Pattern recognition-mediated inflammatory responses 
There are macrophage cells in various vertebrates and invertebrates that are capable of 
recognizing highly conserved pathogenic molecular patterns by receptors called pattern 
recognition receptors (PRRs) [56,57]. These receptors are classified into two major groups, 
one involved in endocytic uptake, such as scavenger receptors (SRs), and the other 
associated with transmission of danger signals independent of endocytosis, such as Toll-like 
receptors (TLRs) and nucleotide-binding domain leucine-rich repeat-containing receptors 
(NLRs) [57,58]. It is of importance to understand signal transduction from these receptors 
for construction of silent drug delivery using particles.  
Lipopolysaccharide (LPS) micelles and silica particles are reported to bind with SRs, which 
binding is followed by their engulfment by macrophages [59-61]. In sepsis patients, SRs play 
a role in efficient clearance of LPS and attenuation of LPS-induced inflammatory responses 
[62]. However, signaling pathways initiated from SRs are difficult to identify, because 
ligands of SRs, such as LPS and polyinosinic acid, simultaneously stimulate TLRs as well. 
Overexpression of class B SRs in human epithelial carcinoma HeLa cells and human 
embryonic kidney cells (HEK293) increases the production of the inflammatory mediator IL-
8 associated with increased uptake of LPS [63]. This inflammatory response seems to be due 
to interaction of SRs with LPS. In contrast, CD163, a hemoglobin scavenger receptor, down-
regulates TH1 inflammatory responses by initiation of signaling leading to secretion of TH2 
cytokines [64]. SRs are associated with TLR-independent signaling pathways and involved 
in inflammatory responses similarly as FcR. 
TLRs play an important role in innate immunity and recognize various molecules derived 
from bacteria and viruses [65]. TLR3 and TLR7 express on the endosomal membrane and 
work as sensors for elimination of unnecessary nucleic acids by induction of 
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inflammatory responses; and these responses should be taken into account for delivery of 
nucleic acids, such as small interfering RNA (siRNA). Administration of siRNA via 
liposomes or transgenic reagent Lipofectamine® induce potent immunostimulation 
generating TH1 inflammatory cytokines from human monocytes and plasmacytoid 
dendritic cells [66,67]. In addition, immune responses through TLRs’ signals cause 
adoptive immunity, such as the generation of antibody [68]. It is of importance to study 
the mechanism of signal transduction associated with TLRs for understanding of the 
generation of undesirable immune responses. To overcome these problems, nanoparticles 
will be effective, because they are able to escape from endosomes into the cytosol, where 
these nanoparticles release drugs. Based on this strategy, delivery of siRNA-containing 
nanoparticles into HeLa cells and human pancreatic carcinoma PanC-1 cells is reported to 
be successful [69,70].   
The role of NLRs should also be taken into consideration in the delivery of particles. One 
of the most characterized NLRs is NLRP3 (also known as NALP3 or cryopyrin) [71]. It is 
noteworthy that the inflammasome (NLRP3), which contains procaspase-1, senses 
lysosomal enzymes in the cytosol, leading to the activation of caspase-1 and that this 
event is followed by secretion of the inflammatory mediators IL-1, IL-18, and IL-33 
[58,72]. Uptake of micro-particles of silica crystals and aluminum hydroxide causes 
leakage of the lysosomal enzyme cathepsin B into the cytosol due to destabilization of the 
lysosomal membrane in human and mouse macrophage cells [73,74]. Possibly, NLRs work 
as a sensor of danger signals initiated from lysosomal destabilization caused by uptake of 
such micro-particles. It should be important to know the effect of undegradable particles 
on the stability of lysosomes for understanding of the onset of cytotoxicity by 
phagocytosis of particles. 
4. Lipid-raft-dependent uptake of particles 
When particles are caught by macrophage cells, the macrophage membrane undergoes 
structural changes after recognition of the particles by endocytic receptors located in  
the membrane region. This membrane region, referred to as a lipid raft, is enriched in 
sphingolipids and cholesterol, which serve as a scaffold for the proper functioning  
of endocytic receptors and various signal transduction pathways [75,76]. In microglia, 
signaling cascades triggered in response to gangliosides are mediated by recruitment  
of Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP-2) to lipid 
rafts [77].  
Caveolae, a subset of lipid rafts, control various biological events including endocytosis [78] 
and are associated with the incorporation of pathogens [79]. There is another possibility that 
inclusion of protein receptors in the rafts is closely associated with phagocytic uptake of 
particles, because CD36, a class B SR, exists in caveolin-containing lipid rafts in human 
melanoma cells [80]. A cyclodextrin, MCD is commonly used as a reagent to disrupt lipid 
rafts by the extraction of cholesterol [81]. Treatment of mouse macrophage-like J774 cells 
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with MCD inhibits recruitment of SRs to lipid raft domain [82]. As a result, phagocytic 
activity toward PSL particles, which are ingested through SRs, decreases. Similarly, 
recruitment of CD36 to raft domains is necessary for phagocytosis of amyloid  by 
microglial cells [83]. Lipid rafts are essential for recruitment of phagocytic receptors; and, 
hence, they are associated with delivery of drug-containing particles by phagocytosis. 
An alternative function of lipid rafts is to provide a scaffold for TLRs associated with danger 
signal transduction. Stimulation of human peripheral blood monocytes with LPS causes 
clustering of the signaling receptor TLR4 with its accessory protein CD14 [84], and 
association of this receptor cluster with lipid rafts is thought to be necessary for LPS-
induced signal transduction [85]. An increase in membrane fluidity due to ethanol at a 
concentration of higher than 50 mM inhibits the association of TLR4 with lipid rafts, 
suppressing LPS-induced TNF- production in mouse macrophage cells [86]. However, it is 
interesting to note that treatment with MCD does not affect LPS-induced gene expression 
relating to inflammation [87]. This could be because MyD88, the adaptor protein of TLR4, 
exists in a membrane region other than lipid rafts [88]. In addition, generation of nitric oxide 
from macrophage cells after disruption of lipid rafts by MCD is comparable to that of intact 
macrophage cells, though the MCD treatment decreases phagocytic activity toward the 
PSL particles by a half [87]. Further studies on the operation of inflammatory signaling 
cascades in relation with lipid rafts are needed. 
5. Endocytosis-mediated drug action 
In the lungs, macrophage cells patrol the air/cell interfaces and play a role in protecting the 
host from invaders such as pathogens and viruses by phagocytic uptake. However, some 
pathogens, such as MTB, survive in macrophage cells and proliferate well by using them as 
incubators after the pathogens have been inhaled into the alveoli by respiration [3]. Owing 
to this survival strategy, MTB is able to escape from the attack of antitubercular agents, and 
this is one of the reasons why effective treatment of TB has not been successful till now.  
As macrophages phagocytose particle formulations besides bacteria and viruses, utilization 
of this phagocytosis-mediated transport of these drug formulations into MTB-infected 
macrophages is expected to be promising for therapy of TB. For this approach, particles 
containing an antitubercular agent are delivered to the lungs, where alveolar macrophages 
infected with MTB reside. The macrophages take up the particles, and the antitubercular 
agent thus phagocytosed in a form of particles attacks the MTB. The effect of PLGA 
microspheres containing rifampicin (RFP), one of the first-line drugs for TB treatment, on 
MTB has been well examined to date [89,90]. PLGA microspheres containing RFP (RFP-
PLGA) were prepared by various methods such as double-emulsification and spray-drying. 
The PLGA MS thus prepared deliver an amount of RFP into rat alveolar macrophage 
NR8383 cells in vitro about 20 times greater than that added in the free form in solution 
[12,37]. Inhalation of PLGA MS containing the antitubercular agent rifabutin increases the 
drug residence time in the lungs to more than that by intravenous administration in mice 
due to uptake of the particles by alveolar phagocytic cells [91]. However, the bacterial 
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population in the rat lung is not significantly decreased by pulmonary administration of 
RFP-PLGA MS, though granuloma formation on the surface of the lung is reduced [92].  
To achieve efficient phagocytosis-mediated TB treatment, at least three requirements must 
be met. Namely, drug-containing particles should be 1) well phagocytosed by alveolar 
macrophages, 2) exhibit a potent bactericidal effect on MTB inside the macrophages, and 3) 
should not be toxic to the phagocytes. PLGA particles containing an antitubercular agent 
well satisfy these three requirements. In addition, homogeneous distribution of drug-
containing particles in the target tissue is required to obtain the optimum effect. 
Understanding of endocytic activities of MTB-infected macrophages toward drug-
containing particles in vivo is thus important for improving TB therapy. 
Another promising aspect of endocytosis-mediated therapy could be the treatment of 
cancer. One possible way would be the induction of inflammatory mediators, such as NO 
and TNF-, in macrophages by immunomodulators such as TLR-ligands, leading to their 
cytotoxic effects on tumor cells [93-95]. In addition, “re-education” of the healing-type 
macrophages (M2 macrophages) to the killer-type macrophages (M1 macrophages) by 
immunomodulators should be effective as well [96]. An increase in the M1 macrophage 
population could be advantageous for the treatment of tumors. As TLRs are expressed on 
various cell membranes in the body, endocytosis-mediated delivery of TLR-ligands to 
macrophage cells should be effective in overcoming malignant neoplasms without the 
induction of undesirable immune responses.  
6. Conclusions 
The physiological function of macrophage cells is important in overcoming various diseases, 
because they rid the body of pathogens by phagocytosis. Hence, phagocytosis-mediated 
drug delivery is useful for a direct attack against pathogenic bacteria and viruses residing 
inside macrophage cells. As summarized in Figure 2, the optimum properties of particles 
targeting macrophage cells are a) “macrophage-philicity,” especially toward phagocytic 
receptors and lipid rafts, b) ability to stimulate actin reorganization, c) a silent nature like a 
“Ninja” with respect to inflammatory responses, and d) ability to allow rapid release of the 
incorporated drugs. Of these, items “a” and “b” refer to the feasibility of particles for their 
efficient ingestion; and spherical particles having about 3-m diameter and surface charges 
are likely to be favorable for phagocytic uptake. Item “c” is associated with a nontoxic effect 
on macrophage function; and item “d” is important for exhibition of drug action, in which 
the release of drugs from the particles modulates the drug action.  
In addition, activation of the macrophages of the immune system is advantageous for attack 
against pathological cells residing close to macrophages, such as tumor cells. It is noteworthy 
that certain bases, such as PLGA, of the particles themselves modulate the immune functions 
of macrophages. Development of drug-containing particles, which efficiently attack the 
pathogens or pathological cells, and which upregulate the immunological function of 
macrophages, is beneficial to overcome infectious diseases and cancer. 
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Figure 2. Biochemical events associated with endocytosis-mediated drug delivery via particles. 
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